Kolon Life Science Inc. (KOSDAQ: 102940)
South Korea
· Delayed Price · Currency is KRW 17,900
+540 (3.11%)
Nov 15, 2024, 9:00 AM KST
Kolon Life Science Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Operating Revenue | 140,273 | 124,639 | 161,584 | 165,485 | 129,413 | 148,541 | Upgrade
|
| Other Revenue | - | - | -0 | -0 | - | -0 | Upgrade
|
| Revenue | 140,273 | 124,639 | 161,584 | 165,485 | 129,413 | 148,541 | Upgrade
|
| Revenue Growth (YoY) | -0.68% | -22.86% | -2.36% | 27.87% | -12.88% | 5.16% | Upgrade
|
| Cost of Revenue | 127,031 | 112,343 | 124,567 | 128,381 | 110,677 | 123,178 | Upgrade
|
| Gross Profit | 13,242 | 12,296 | 37,017 | 37,104 | 18,736 | 25,363 | Upgrade
|
| Selling, General & Admin | 19,539 | 20,149 | 19,581 | 17,696 | 27,772 | 30,192 | Upgrade
|
| Research & Development | 16,207 | 14,892 | 13,583 | 14,327 | 13,154 | 18,490 | Upgrade
|
| Other Operating Expenses | 253.72 | 242.57 | 198.91 | 207.68 | 696.14 | 469.5 | Upgrade
|
| Operating Expenses | 37,045 | 36,391 | 34,375 | 32,855 | 44,571 | 51,906 | Upgrade
|
| Operating Income | -23,803 | -24,095 | 2,642 | 4,249 | -25,835 | -26,543 | Upgrade
|
| Interest Expense | -7,042 | -5,857 | -3,722 | -6,013 | -5,518 | -3,741 | Upgrade
|
| Interest & Investment Income | 170.48 | 168.59 | 114.07 | 120.4 | 135.4 | 460.2 | Upgrade
|
| Currency Exchange Gain (Loss) | 64.55 | -348.04 | -20.33 | 273.77 | -814.81 | 194.06 | Upgrade
|
| Other Non Operating Income (Expenses) | -50,508 | -312.22 | 7,959 | 1,600 | -13,646 | -49,060 | Upgrade
|
| EBT Excluding Unusual Items | -81,119 | -30,444 | 6,972 | 230.15 | -45,679 | -78,690 | Upgrade
|
| Gain (Loss) on Sale of Investments | - | -14.53 | -5.18 | 11.07 | - | 500 | Upgrade
|
| Gain (Loss) on Sale of Assets | -7.01 | -6.9 | -20.9 | 75.12 | 3,573 | -131.93 | Upgrade
|
| Asset Writedown | -3,138 | -3,133 | -2,822 | -4,327 | -1,090 | -1,875 | Upgrade
|
| Pretax Income | -84,264 | -33,598 | 4,124 | -4,011 | -43,195 | -80,197 | Upgrade
|
| Income Tax Expense | -30.14 | 1.25 | 107.93 | -2,636 | - | 12,127 | Upgrade
|
| Earnings From Continuing Operations | -84,234 | -33,599 | 4,016 | -1,375 | -43,195 | -92,323 | Upgrade
|
| Earnings From Discontinued Operations | -52.88 | 2,873 | -1,883 | - | - | - | Upgrade
|
| Net Income | -84,287 | -30,726 | 2,133 | -1,375 | -43,195 | -92,323 | Upgrade
|
| Net Income to Common | -84,287 | -30,726 | 2,133 | -1,375 | -43,195 | -92,323 | Upgrade
|
| Shares Outstanding (Basic) | 11 | 11 | 11 | 11 | 11 | 11 | Upgrade
|
| Shares Outstanding (Diluted) | 11 | 11 | 13 | 11 | 11 | 11 | Upgrade
|
| Shares Change (YoY) | 0.46% | -9.69% | 10.85% | - | -0.01% | 22.77% | Upgrade
|
| EPS (Basic) | -7367.96 | -2692.37 | 186.96 | -120.61 | -3789.00 | -8098.00 | Upgrade
|
| EPS (Diluted) | -7367.96 | -2692.37 | 169.00 | -121.00 | -3789.00 | -8098.00 | Upgrade
|
| Free Cash Flow | -39,604 | -35,009 | -27,159 | -20,600 | -10,050 | -50,960 | Upgrade
|
| Free Cash Flow Per Share | -3462.04 | -3067.66 | -2149.14 | -1807.01 | -881.60 | -4469.86 | Upgrade
|
| Gross Margin | 9.44% | 9.87% | 22.91% | 22.42% | 14.48% | 17.07% | Upgrade
|
| Operating Margin | -16.97% | -19.33% | 1.63% | 2.57% | -19.96% | -17.87% | Upgrade
|
| Profit Margin | -60.09% | -24.65% | 1.32% | -0.83% | -33.38% | -62.15% | Upgrade
|
| Free Cash Flow Margin | -28.23% | -28.09% | -16.81% | -12.45% | -7.77% | -34.31% | Upgrade
|
| EBITDA | -15,355 | -15,264 | 12,109 | 15,549 | -12,806 | -12,504 | Upgrade
|
| EBITDA Margin | -10.95% | -12.25% | 7.49% | 9.40% | -9.90% | -8.42% | Upgrade
|
| D&A For EBITDA | 8,448 | 8,831 | 9,467 | 11,299 | 13,030 | 14,039 | Upgrade
|
| EBIT | -23,803 | -24,095 | 2,642 | 4,249 | -25,835 | -26,543 | Upgrade
|
| EBIT Margin | -16.97% | -19.33% | 1.63% | 2.57% | -19.96% | -17.87% | Upgrade
|
| Effective Tax Rate | - | - | 2.62% | - | - | - | Upgrade
|
| Advertising Expenses | - | 153.71 | 30 | 0.82 | 4.1 | 95.7 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.